Market Access Radar (MAR) provides quick and easy access to the most important market access (MA)-related information. MAR insights display in an easy-to-follow layout and present the most relevant data directly to you when you need it. Our MAR team gathers the latest reimbursement recommendations and information on financing from public funds announced by Ministries of Health and HTA agencies. This information provides changes in legal provisions regulating financing of health technologies from public funds. In addition, our team gathers the latest news on drug safety, new marketing authorisations, variations in registered and reimbursed indications published by EMA, HMA, FDA, MHRA, Ministries of Health and other national institutions responsible for registration and safety of drugs and other valuable information which may impact reimbursement, published in mass-media and relevant press.